DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Chen L, Zhou W, Hu X, Yi M, Ye C, Yao G.
Short-duration versus 1-year adjuvant trastuzumab in early HER2 positive breast cancer: a meta-analysis of randomized controlled trials.
Cancer Treat Rev 2019;
75: 12-19
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.